BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 8058153)

  • 1. Adjuvant therapy with dibromodulcitol and BCNU increases survival of adults with malignant gliomas. EORTC Brain Tumor Group.
    Hildebrand J; Sahmoud T; Mignolet F; Brucher JM; Afra D
    Neurology; 1994 Aug; 44(8):1479-83. PubMed ID: 8058153
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phase I evaluation of preirradiation chemotherapy with carmustine and cisplatin and accelerated radiation therapy in patients with high-grade gliomas.
    Rajkumar SV; Buckner JC; Schomberg PJ; Pitot HC; Ingle JN; Cascino TL
    Neurosurgery; 1999 Jan; 44(1):67-73. PubMed ID: 9894965
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adjuvant dibromodulcitol and BCNU chemotherapy in anaplastic astrocytoma: results of a randomised European Organisation for Research and Treatment of Cancer phase III study (EORTC study 26882).
    Hildebrand J; Gorlia T; Kros JM; Afra D; Frenay M; Omuro A; Stupp R; Lacombe D; Allgeier A; van den Bent MJ;
    Eur J Cancer; 2008 Jun; 44(9):1210-6. PubMed ID: 18248979
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radiation therapy and hydroxyurea followed by the combination of 6-thioguanine and BCNU for the treatment of primary malignant brain tumors.
    Prados MD; Larson DA; Lamborn K; McDermott MW; Sneed PK; Wara WM; Chang SM; Mack EE; Krouwer HG; Chandler KL; Warnick RE; Davis RL; Rabbitt JE; Malec M; Levin VA; Gutin PH; Phillips TL; Wilson CB
    Int J Radiat Oncol Biol Phys; 1998 Jan; 40(1):57-63. PubMed ID: 9422558
    [TBL] [Abstract][Full Text] [Related]  

  • 5. BCNU-DBD (Dibromodulcitol) chemotherapy of recurrent supratentorial anaplastic astrocytomas and glioblastomas.
    Vitanovics D; Sipos L; Afra D
    Neoplasma; 2002; 49(5):342-5. PubMed ID: 12458335
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Chemotherapy of recurrent supratentorial malignant gliomas (phase II study)].
    Afra D; Sipos L; Vitanovics D
    Ideggyogy Sz; 2002 Jan; 55(1-2):38-44. PubMed ID: 12122942
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phase I and pharmacokinetic study of preirradiation chemotherapy with BCNU, cisplatin, etoposide, and accelerated radiation therapy in patients with high-grade glioma.
    Rajkumar SV; Buckner JC; Schomberg PJ; Reid JM; Bagniewski PJ; Ames MM; Cascino TL; Marks RS
    Int J Radiat Oncol Biol Phys; 1998 Dec; 42(5):969-75. PubMed ID: 9869217
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phase I evaluation of radiation combined with recombinant interferon alpha-2a and BCNU for patients with high-grade glioma.
    Rajkumar SV; Buckner JC; Schomberg PJ; Cascino TL; Burch PA; Dinapoli RP
    Int J Radiat Oncol Biol Phys; 1998 Jan; 40(2):297-302. PubMed ID: 9457812
    [TBL] [Abstract][Full Text] [Related]  

  • 9. BCNU wafer placement with temozolomide (TMZ) in the immediate postoperative period after tumor resection followed by radiation therapy with TMZ in patients with newly diagnosed high grade glioma: final results of a prospective, multi-institutional, phase II trial.
    Burri SH; Prabhu RS; Sumrall AL; Brick W; Blaker BD; Heideman BE; Boltes P; Kelly R; Symanowski JT; Wiggins WF; Ashby L; Norton HJ; Judy K; Asher AL
    J Neurooncol; 2015 Jun; 123(2):259-66. PubMed ID: 25947286
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Randomized trial of radiation therapy (RT) plus dibromodulcitol (DBD) versus RT plus BCNU in high grade astrocytoma.
    Elliott TE; Dinapoli RP; O'Fallon JR; Krook JE; Earle JD; Morton RF; Levitt R; Tschetter LK; Scheithauer BW; Pfeifle DM; Twito DI; Nelimark RA
    J Neurooncol; 1997 Jul; 33(3):239-50. PubMed ID: 9195495
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Hyperfractionated radiotherapy and adjuvant chemotherapy in patients with malignant gliomas].
    Jeremić V; Grujicić D; Samarcić M; Antunović V; Joksimović M; Milicić B; Rasulić L; Nikolić N
    Srp Arh Celok Lek; 1997; 125(11-12):333-9. PubMed ID: 9480566
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phase II study of 6-thioguanine, procarbazine, dibromodulcitol, lomustine, and vincristine chemotherapy with radiotherapy for treating malignant glioma in children.
    Levin VA; Lamborn K; Wara W; Davis R; Edwards M; Rabbitt J; Malec M; Prados MD
    Neuro Oncol; 2000 Jan; 2(1):22-8. PubMed ID: 11302250
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phase 1 study of 28-day, low-dose temozolomide and BCNU in the treatment of malignant gliomas after radiation therapy.
    Raizer JJ; Malkin MG; Kleber M; Abrey LE
    Neuro Oncol; 2004 Jul; 6(3):247-52. PubMed ID: 15279717
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phase II trial of thalidomide and carmustine for patients with recurrent high-grade gliomas.
    Fine HA; Wen PY; Maher EA; Viscosi E; Batchelor T; Lakhani N; Figg WD; Purow BW; Borkowf CB
    J Clin Oncol; 2003 Jun; 21(12):2299-304. PubMed ID: 12805330
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Response of recurrent glioblastoma and anaplastic astrocytoma to dibromodulcitol, BCNU and procarbazine--a phase-II study.
    Hildebrand J; De Witte O; Sahmoud T
    J Neurooncol; 1998 Apr; 37(2):155-60. PubMed ID: 9524094
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dibromodulcitol-based combined postoperative chemotherapy of malignant astrocytomas and glioblastomas.
    Afra D; Kocsis B; Kerpel-Fronius S; Eckhardt S
    J Neurooncol; 1986; 4(1):65-70. PubMed ID: 3746387
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phase III comparative evaluation of PCNU and carmustine combined with radiation therapy for high-grade glioma.
    Dinapoli RP; Brown LD; Arusell RM; Earle JD; O'Fallon JR; Buckner JC; Scheithauer BW; Krook JE; Tschetter LK; Maier JA
    J Clin Oncol; 1993 Jul; 11(7):1316-21. PubMed ID: 8315428
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A phase III randomized prospective trial of external beam radiotherapy, mitomycin C, carmustine, and 6-mercaptopurine for the treatment of adults with anaplastic glioma of the brain. CNS Cancer Consortium.
    Halperin EC; Herndon J; Schold SC; Brown M; Vick N; Cairncross JG; Macdonald DR; Gaspar L; Fischer B; Dropcho E; Rosenfeld S; Morowitz R; Piepmeier J; Hait W; Byrne T; Salter M; Imperato J; Khandekar J; Paleologos N; Burger P; Bentel GC; Friedman A
    Int J Radiat Oncol Biol Phys; 1996 Mar; 34(4):793-802. PubMed ID: 8598355
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phase III trial of carmustine and cisplatin compared with carmustine alone and standard radiation therapy or accelerated radiation therapy in patients with glioblastoma multiforme: North Central Cancer Treatment Group 93-72-52 and Southwest Oncology Group 9503 Trials.
    Buckner JC; Ballman KV; Michalak JC; Burton GV; Cascino TL; Schomberg PJ; Hawkins RB; Scheithauer BW; Sandler HM; Marks RS; O'Fallon JR; ;
    J Clin Oncol; 2006 Aug; 24(24):3871-9. PubMed ID: 16921039
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combination chemotherapy with carmustine and cisplatin before, during, and after radiotherapy for adult malignant gliomas.
    Kiu MC; Chang CN; Cheng WC; Lin TK; Wong CW; Tang SG; Leung WM; Chen LH; Ho YS; Ng KT
    J Neurooncol; 1995; 25(3):215-20. PubMed ID: 8592171
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.